Publications by authors named "Daniel Ahn"

Claim this Profile
E
Evaluating third-line therapies in refractory metastatic colorectal cancer: a systematic review and network meta-analysis.
Celine Hoyek, Syed Arsalan Ahmed Naqvi, Oudai Sahvan, Fares Jamal, Kunwer Sufyan Faisal, Daniel H Ahn

Dig Liver Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 study.
Cody Eslinger, Daniel Walden, Alexandra Krivonos, Numrah Fadra, Tyler Zemla, Daniel Ahn

Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to DNA-damaging agents and PARP inhibitors in ATM mutated metastatic colorectal cancer: case series.
Cody Eslinger, Daniel Walden, Mohamad Bassam Sonbol, Daniel Ahn, Christina Wu

Chin Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study.
Ioannis Kournoutas, Paulina Marell, Jennifer Gile, Anina Peersen, Priyanshi Shah, Daniel Ahn

Oncologist· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low rates of inotropic support and durable left ventricular assist device placement among status 2 heart transplant candidates with temporary mechanical circulatory support.
Daniel J Ahn, Molly White, Gege Ran, Nikhil Narang, Manreet Kanwar

J Heart Lung Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo Clinic.
Oudai Sahwan, Fares Jamal, Rish Pai, Cody Eslinger, Shaylene McCue, Daniel Ahn

JCO Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 study of the novel GCN2 kinase activator NXP800 in patients with advanced cholangiocarcinoma.
Hendrien Kuipers, Joseph J Larson, Caitlin B Conboy, Daniel H Ahn, Tanios Bekaii-Saab

Future Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical outcomes of cabozantinib as a second-line treatment for advanced hepatocellular carcinoma: a retrospective US claims analysis.
Daniel H Ahn, Noh Jin Park, Michael Locker, Zheng-Yi Zhou, Xiaoyu Nie

Oncologist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors.
Himil Mahadevia, Umair Majeed, Jaydeepbhai Patel, Ahmed K Ahmed, Ahmed Elhariri, Daniel Ahn

JAMA Netw Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Rate of Transplantation Prior to Review of Status Exception Requests among Adult Heart Transplant Candidates.
Daniel J Ahn, Toshihiro Nakayama, Antony Attia, Molly White, Dalin Eap

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications and Status Upgrades among Adult Heart Transplant Candidates with Durable LVADs: Waiting 6 to 8 Years for Status Escalation Is Too Long.
Daniel J Ahn, Antony Attia, Toshihiro Nakayama, Nikhil Narang, Kiran K Khush

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Analysis of Rectal Cancer Biopsies With the Digital Pathology Segmentation Algorithm QuantCRC Associates With Therapy Response and Recurrence.
Reetesh K Pai, Cody Eslinger, Kenneth Lee, Lama Farhat Farchoukh, Daniel Walden, Daniel Ahn

Lab Invest· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of perioperative and neoadjuvant therapies in gastric and gastroesophageal junction adenocarcinoma: a network meta-analysis.
Muhammad Umair Anjum, Syed Arsalan Ahmed Naqvi, Salman Ayub Jajja, Ammad Raina, Muhammad Umar Afzal, Daniel H Ahn

Oncologist· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of -Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.
Daniel H Ahn, Maya Ridinger, Timothy L Cannon, Lawrence Mendelsohn, Jason S Starr

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential Treatment with Regorafenib and Trifluridine/Tipiracil ± Bevacizumab in Refractory Metastatic Colorectal Cancer in Community Clinical Practice in the USA.
Daniel H Ahn, Tanios S Bekaii-Saab, Chengbo Yuan, Milena Kurtinecz, Xiaoyun Pan

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLO25-095: Baseline Genomic Alterations as Predictors of Response to Anti-HER2 Therapy in HER2-Amplified Advanced Colorectal Cancer (aCRC).
Celine Hoyek, Angelo Pirozzi, Binbin Zheng, Naoko Lida, Ryne Ramaker, Daniel H Ahn

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of nonstandardized model for end-stage liver disease score exceptions with waitlist mortality in adult liver transplant candidates.
Daniel J Ahn, Allison J Kwong, Anji E Wall, William F Parker

Am J Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy.
Cody Eslinger, Daniel Walden, Alyssa McGary, Oluwadunni Emiloju, Daniel Ahn

Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-care ultrasound training among anesthesiology residency programs in the United States.
Jordon Edwards, Daniel Ahn, Daniel Alcaraz, Collin Chiles, Tina Khuu

BMC Anesthesiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study.
Farshid Dayyani, Heide A Stirnadel-Farrant, Jenny Hu, Yian Lin, Nehemiah Kebede, Daniel H Ahn

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer.
Oluseyi Abidoye, Daniel H Ahn, Mitesh J Borad, Christina Wu, Tanios Bekaii-Saab

Cells· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer.
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Juan W Valle, Chigusa Morizane, Daniel H Ahn

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of commercial portable ex vivo lung perfusion at a low-volume US lung transplant center.
Johnathan Kent, Rachel Nordgren, Daniel Ahn, Maria Lysandrou, Ashley Diaz

Artif Organs· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature.
Cody Eslinger, Christina Wu, Daniel H Ahn

J Gastrointest Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma.
Aakash Desai, Alexander H Xiao, Daheui Choi, Merih D Toruner, Daniel Walden, Daniel Ahn

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis